GlassScriptPhysician profile
Vincenzo Galati
NPI 1376693754
$9,097.33
in general payments reported to CMS, 2019-2025
49 companies · $1,148 in 2025
The $1,148 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $944 · 2020: $332 · 2021: $2,084 · 2022: $1,246 · 2023: $2,240 · 2024: $1,103 · 2025: $1,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,107 · Travel and Lodging: $384.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,106.56 |
| Travel and Lodging | $383.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,578.38 | 2021-2025 | Urolift, Barrigel |
| Astellas Pharma US INC | $1,130.68 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Abbvie INC. | $723.75 | 2019-2025 | |
| Medtronic, INC. | $660.74 | 2023 | Interstim |
| Edap Technomed INC | $432.00 | 2024 | |
| Merck Sharp & Dohme LLC | $398.64 | 2021-2025 | Keytruda, Lynparza, Welireg |
| Boston Scientific Corporation | $330.68 | 2019-2025 | Spaceoar Vue System - 10ml, Lithovue, Lithovue Elite |
| Myriad Genetic Laboratories, INC. | $326.76 | 2021-2025 | Prolaris |
| Pfizer INC. | $280.94 | 2019-2025 | |
| Dendreon Pharmaceuticals LLC | $275.28 | 2022-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $209.92 | 2019-2025 | |
| Janssen Biotech, INC. | $190.72 | 2019-2025 | Erleada |
| Angiodynamics, INC. | $171.23 | 2023 | Nanoknife |
| Urogen Pharma, INC. | $169.58 | 2021-2024 | Jelmyto |
| Procept Biorobotics Corporation | $162.04 | 2023-2025 | Aquabeam Robotic System |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $160.95 | 2019-2025 | |
| Rochester Medical Corporation | $134.95 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $128.80 | 2019-2023 | Bard Urinary Drainage Bag |
| Blue Earth Diagnostics | $124.73 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $121.52 | 2024-2025 | Adstiladrin |
| Amgen INC. | $121.10 | 2019-2023 | Prolia |
| Myovant Sciences INC. | $113.57 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $95.39 | 2019-2025 | |
| Allergan, INC. | $86.69 | 2020-2022 | |
| Travere Therapeutics, INC. | $81.42 | 2019-2021 | |
| Intuitive Surgical, INC. | $69.45 | 2019 | |
| Innovation Technologies INC | $69.38 | 2023 | Irrisept |
| Endo USA, INC. | $66.40 | 2024-2025 | Xiaflex |
| Sumitomo Pharma America, INC. | $63.99 | 2023-2024 | Orgovyx |
| Axonics, INC. | $63.56 | 2020-2024 | Axonics |
| Calyxo, INC. | $63.19 | 2024-2025 | Cvac Aspiration System |
| Ethicon INC. | $58.45 | 2021 | |
| Neotract INC. | $47.08 | 2019-2020 | |
| Genzyme Corporation | $46.64 | 2021-2022 | |
| Olympus America INC. | $31.37 | 2021-2025 | Itind System |
| Tolmar, INC. | $31.32 | 2023 | |
| Laborie Medical Technologies Corp. | $29.63 | 2024 | Optilume Bph Drug Coated Balloon Catheter, Goby |
| Cumberland Pharmaceuticals, INC. | $27.75 | 2021-2023 | Caldolor |
| Astrazeneca Pharmaceuticals LP | $25.33 | 2025 | Lynparza |
| Progenics Pharmaceuticals, INC. | $25.31 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $24.50 | 2022 | |
| Cook Medical LLC | $23.51 | 2025 | Cook |
| Pacira Pharmaceuticals Incorporated | $21.55 | 2024 | Exparel |
| Telix Pharmaceuticals | $18.57 | 2023 | Illuccix |
| Vertex Pharmaceuticals Incorporated | $17.69 | 2025 | |
| Zyla Life Sciences, INC. | $16.76 | 2019 | |
| Alnylam Pharmaceuticals INC. | $15.89 | 2021 | |
| Caris Mpi, INC. | $15.20 | 2025 | Mi Cancer Seek |
| Celgene Corporation | $14.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vincenzo Galati listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.